JATT II 10-Q Discloses $225M PIPE Financing Terms for Talawar Merger
JATT sits 28% above its 52-week low of $10.
Summary
JATT II's Q2 10-Q reveals the $225 million PIPE financing terms for its Talawar Therapeutics merger, including a $125 million minimum cash condition and Sponsor share surrender.
Key Events · M&A and Partnerships · JATT
-
PIPE Financing Terms Quantified
PIPE investors agreed to purchase 22.5 million Talawar shares at $10.00 per share for $225 million, implying a $120 million pre-PIPE equity valuation.
-
Minimum Cash Condition
Talawar's obligation to close is conditioned on available cash being at least $125 million after payment or accrual of certain expenses.
-
Sponsor Share Surrender
Under the Sponsor Support Agreement, the Sponsor will surrender 150,000 ordinary shares for no consideration at closing.
-
Equity Incentive Plan
Post-closing, Talawar will reserve 12% of fully-diluted shares for an equity incentive plan, with an automatic 5% annual increase.
Analysis · JATT · Real Estate & Construction
The 10-Q quantifies the PIPE financing backing the Talawar Therapeutics merger: 22.5 million shares at $10.00 each for $225 million, implying a $120 million pre-PIPE equity valuation. It also discloses a $125 million minimum available cash condition for Talawar to close, and that the Sponsor will surrender 150,000 shares for no consideration. These are material new terms not in the June 29 announcement, giving investors a clearer picture of the deal's capital structure and closing requirements.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 35.7% of the 1024 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JATT was trading at $12.85 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $103.1M. The 52-week trading range was $10.00 to $13.80. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.